should i start with semaglutide or tirzepatide vs Tirzepatide: Head-to-Head for Weight Loss & Diabetes Switching from semaglutide to tirzepatide

GLP-1 medications produce roughly 50-100% more weight loss than Qsymia at their respective top doses

The STEP 1 trial (Wilding et al., The Lancet, 2021) showed an average weight loss of 14.9% over 68 weeks versus 2.4% in the placebo group a landmark result that established semaglutide as the benchmark for GLP-1 weight loss

Currently, 70% of the GLP-1 market is in the US and partially the EU, with a staggering 300% growth from 2020 to 2023 in prescriptions within the US alone

Mounjaros innovative dual-action mechanism provides broader weight loss and glycemic control compared to traditional GLP-1 medications

Let us see how it happens